Skip to main content
Free access
ORIGINAL REPORTS
July 16, 2012

Bortezomib Induction and Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma: Results of the Randomized Phase III HOVON-65/ GMMG-HD4 Trial

Publication: Journal of Clinical Oncology

Authors' Disclosures of Potential Conflicts of Interest

Although all authors completed the disclosure declaration, the following author(s) and/or an author's immediate family member(s) indicated a financial or other interest that is relevant to the subject matter under consideration in this article. Certain relationships marked with a “U” are those for which no compensation was received; those relationships marked with a “C” were compensated. For a detailed description of the disclosure categories, or for more information about ASCO's conflict of interest policy, please refer to the Author Disclosure Declaration and the Disclosures of Potential Conflicts of Interest section in Information for Contributors.
Employment or Leadership Position: Helgi van der Velde, Janssen Pharmaceuticals (C) Consultant or Advisory Role: Pieter Sonneveld, Celgene (C), Janssen Pharmaceuticals (C), Millennium Pharmaceuticals (C); Ingo G.H. Schmidt-Wolf, Janssen Pharmaceuticals (C); Hans Salwender, Janssen Pharmaceuticals (C); Sonja Zweegman, Janssen Pharmaceuticals (C); Katja C. Weisel, Celgene (C); Hartmut M. Goldschmidt, Celgene (C), Janssen Pharmaceuticals (C) Stock Ownership: Helgi van der Velde, Johnson & Johnson Honoraria: Pieter Sonneveld, Janssen Pharmaceuticals, Millennium Pharmaceuticals; Ingo G.H. Schmidt-Wolf, Janssen Pharmaceuticals; Hans Salwender, Celgene, Janssen Pharmaceuticals; Katja C. Weisel, Celgene, Janssen Pharmaceuticals; Christof Scheid, Celgene, Janssen Pharmaceuticals, Novartis; Ulrich Duehrsen, Janssen-Cilag; Hartmut M. Goldschmidt, Celgene, Chugai Pharmaceutical, Janssen Pharmaceuticals, Novartis Research Funding: Pieter Sonneveld, Celgene, Janssen Pharmaceuticals; Katja C. Weisel, Celgene; Hartmut M. Goldschmidt, Celgene, Janssen Pharmaceuticals Expert Testimony: None Other Remuneration: Hans Salwender, Celgene, Janssen Pharmaceuticals

Affiliations

Pieter Sonneveld and Annemiek Broyl, Erasmus Medical Center; Bronno van der Holt and Laila el Jarari, Erasmus Medical Center-Daniel den Hoed Cancer Center, Rotterdam; Sonja Zweegman, Vreij Universitet University Medical Center; Marie-Jose Kersten, Academic Medical Center, Amsterdam; Edo Vellenga, University Medical Center Groningen, Groningen; Shulamiet Wittebol, Meander Medical Center, Amersfoort; Gerard M.J. Bos, Maastricht University Medical Center, Maastricht; Marian Stevens-Kroef and Reinier Raymakers, University Medical Center Nijmegen, Nijmegen; Martijn R. Schaafsma, Medical Spectrum Twente, Enschede; Marinus van Marwijk-Kooy, Isala Clinics, Zwolle; Pierre W. Wijermans, Haga Hospital, the Hague; Henk M. Lokhorst, Utrecht Medical Center, Utrecht, the Netherlands; Ingo G.H. Schmidt-Wolf, University of Bonn, Bonn; Uta Bertsch, Dirk Hose, Anna Jauch, and Hartmut M. Goldschmidt, University Hospital of Heidelberg, Heidelberg; Hans Salwender, Asklepios Klinik Altona, Hamburg; Igor Wolfgang Blau, Charité Campus Benjamin Franklin, Berlin; Katja Christina Weisel, University of Tuebingen, Tuebingen; Christof Scheid, University Hospital of Cologne, Cologne; Michael Pfreundschuh, Saarland University Medical School, Homburg/Saar; Ulrich Duehrsen, University Hospital Essen, Essen; Walter Lindemann, Katholische Krankenhaus Hagen, Hagen, Germany; and Helgi van der Velde, Janssen Pharmaceuticals, Beerse, Belgium.

Information & Authors

Information

Published In

Journal of Clinical Oncology
Pages: 2946 - 2955
PubMed: 22802322

History

Published online: July 16, 2012
Published in print: August 20, 2012

Permissions

Request permissions for this article.

Authors

Affiliations

Pieter Sonneveld [email protected]
Author affiliations appear at the end of this article.
Ingo G.H. Schmidt-Wolf
Author affiliations appear at the end of this article.
Bronno van der Holt
Author affiliations appear at the end of this article.
Laila el Jarari
Author affiliations appear at the end of this article.
Uta Bertsch
Author affiliations appear at the end of this article.
Hans Salwender
Author affiliations appear at the end of this article.
Sonja Zweegman
Author affiliations appear at the end of this article.
Edo Vellenga
Author affiliations appear at the end of this article.
Annemiek Broyl
Author affiliations appear at the end of this article.
Igor W. Blau
Author affiliations appear at the end of this article.
Katja C. Weisel
Author affiliations appear at the end of this article.
Shulamiet Wittebol
Author affiliations appear at the end of this article.
Gerard M.J. Bos
Author affiliations appear at the end of this article.
Marian Stevens-Kroef
Author affiliations appear at the end of this article.
Christof Scheid
Author affiliations appear at the end of this article.
Michael Pfreundschuh
Author affiliations appear at the end of this article.
Dirk Hose
Author affiliations appear at the end of this article.
Anna Jauch
Author affiliations appear at the end of this article.
Helgi van der Velde
Author affiliations appear at the end of this article.
Reinier Raymakers
Author affiliations appear at the end of this article.
Martijn R. Schaafsma
Author affiliations appear at the end of this article.
Marie-Jose Kersten
Author affiliations appear at the end of this article.
Marinus van Marwijk-Kooy
Author affiliations appear at the end of this article.
Ulrich Duehrsen
Author affiliations appear at the end of this article.
Walter Lindemann
Author affiliations appear at the end of this article.
Pierre W. Wijermans
Author affiliations appear at the end of this article.
Henk M. Lokhorst
Author affiliations appear at the end of this article.
Hartmut M. Goldschmidt
Author affiliations appear at the end of this article.

Notes

Corresponding author: Pieter Sonneveld, MD, PhD, Department of Hematology, Erasmus Medical Center, Dr Molewaterplein 40, Room L 407, PO Box 2040, Rotterdam, the Netherlands 3000 CA; e-mail: [email protected].

Author Contributions

Conception and design: Pieter Sonneveld, Ingo G.H. Schmidt-Wolf, Sonja Zweegman, Edo Vellenga, Gerard M.J. Bos, Dirk Hose, Marinus van Marwijk-Kooy, Pierre W. Wijermans, Henk M. Lokhorst, Hartmut M. Goldschmidt
Financial support: Helgi van der Velde
Administrative support: Bronno van der Holt, Laila el Jarari, Uta Bertsch, Henk M. Lokhorst, Hartmut M. Goldschmidt
Provision of study materials or patients: Pieter Sonneveld, Ingo G.H. Schmidt-Wolf, Hans Salwender, Sonja Zweegman, Edo Vellenga, Igor W. Blau, Katja C. Weisel, Shulamiet Wittebol, Gerard M.J. Bos, Marian Stevens-Kroef, Christof Scheid, Michael Pfreundschuh, Dirk Hose, Helgi van der Velde, Reinier Raymakers, Martijn R. Schaafsma, Marie-Jose Kersten, Marinus van Marwijk-Kooy, Ulrich Duehrsen, Walter Lindemann, Pierre W. Wijermans, Henk M. Lokhorst, Hartmut M. Goldschmidt
Collection and assembly of data: Pieter Sonneveld, Ingo G.H. Schmidt-Wolf, Laila el Jarari, Uta Bertsch, Hans Salwender, Sonja Zweegman, Edo Vellenga, Annemiek Broyl, Igor W. Blau, Katja C. Weisel, Shulamiet Wittebol, Gerard M.J. Bos, Marian Stevens-Kroef, Christof Scheid, Michael Pfreundschuh, Anna Jauch, Reinier Raymakers, Martijn R. Schaafsma, Marie-Jose Kersten, Marinus van Marwijk-Kooy, Ulrich Duehrsen, Walter Lindemann, Pierre W. Wijermans, Henk M. Lokhorst, Hartmut M. Goldschmidt
Data analysis and interpretation: Pieter Sonneveld, Ingo G.H. Schmidt-Wolf, Bronno van der Holt, Laila el Jarari, Sonja Zweegman, Marian Stevens-Kroef, Christof Scheid, Dirk Hose, Helgi van der Velde, Pierre W. Wijermans, Henk M. Lokhorst, Hartmut M. Goldschmidt
Manuscript writing: All authors
Final approval of manuscript: All authors

Funding Information

Supported by the Dutch Cancer Foundation, the German Federal Ministry of Education and Research, and unrestricted Grant No. MMY3003 from Janssen-Cilag-Ortho Biotech. The German Multicenter Myeloma Group was supported by grants from Novartis, Amgen (No. P2004-0060), Chugai, and Roche.

Metrics & Citations

Metrics

Altmetric

Citations

Article Citation

Download Citation

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format





Download article citation data for:
Pieter Sonneveld, Ingo G.H. Schmidt-Wolf, Bronno van der Holt, Laila el Jarari, Uta Bertsch, Hans Salwender, Sonja Zweegman, Edo Vellenga, Annemiek Broyl, Igor W. Blau, Katja C. Weisel, Shulamiet Wittebol, Gerard M.J. Bos, Marian Stevens-Kroef, Christof Scheid, Michael Pfreundschuh, Dirk Hose, Anna Jauch, Helgi van der Velde, Reinier Raymakers, Martijn R. Schaafsma, Marie-Jose Kersten, Marinus van Marwijk-Kooy, Ulrich Duehrsen, Walter Lindemann, Pierre W. Wijermans, Henk M. Lokhorst, Hartmut M. Goldschmidt
Journal of Clinical Oncology 2012 30:24, 2946-2955

View Options

View options

View Full Text HTML

View Full Text HTML

Get Access

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login

Purchase Options

Purchase this article to get full access to it.

Purchase this Article

Subscribe

Subscribe to this Journal
Renew Your Subscription
Become a Member

Media

Figures

Other

Tables

Share

Share

Share article link

Share